| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/21/2003 | CN1419448A Remedies |
| 05/21/2003 | CN1419437A Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 05/21/2003 | CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound |
| 05/21/2003 | CN1418870A 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 05/21/2003 | CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 05/21/2003 | CN1418704A SOD nutriment capsule with high micro content |
| 05/21/2003 | CN1418642A Process for prodn. of biological prepn. for antisenesence |
| 05/21/2003 | CN1109032C Compounds analogous to thalidomide from class comprising pipeidine-2,6-diones |
| 05/21/2003 | CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof |
| 05/21/2003 | CN1108967C Metering valve |
| 05/21/2003 | CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates |
| 05/21/2003 | CN1108799C Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 05/21/2003 | CN1108797C Quinazolinone pharmaceuticals and use thereof |
| 05/21/2003 | CN1108795C Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or doner, or a nitric oxide inhibitor |
| 05/20/2003 | US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis |
| 05/20/2003 | US6566543 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury |
| 05/20/2003 | US6566538 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 05/20/2003 | US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566491 Cyclopeptide derivatives |
| 05/20/2003 | US6566401 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine |
| 05/20/2003 | US6566398 Method for treatment of external secretion disorders |
| 05/20/2003 | US6566390 Inhibiting a PTPase treating type 1 and 2 diabetes, insulin resistance and pathological obesity |
| 05/20/2003 | US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock |
| 05/20/2003 | US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 05/20/2003 | US6566376 Diphenyl-piperidine derivative |
| 05/20/2003 | US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer |
| 05/20/2003 | US6566370 Administering decahydroisoquinoline-3-carboxylic acid derivative for therapy of migraine |
| 05/20/2003 | US6566368 Aministering apomorphine or a pharmaceutically acceptable acid addition salt thereof intranasally and in an amount sufficient to induce an erection adequate for vaginal penetration but less than the amount that induces substantial nausea |
| 05/20/2003 | US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines |
| 05/20/2003 | US6566366 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 05/20/2003 | US6566364 Linear or cyclic ureas |
| 05/20/2003 | US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation |
| 05/20/2003 | US6566360 2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors |
| 05/20/2003 | US6566358 Cyclocarbamate derivatives as progesterone receptor modulators |
| 05/20/2003 | US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 05/20/2003 | US6566355 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens |
| 05/20/2003 | US6566338 Administering caspase inhibitor for therapy of oral mucositis, gastrointestinal mucositis, bladder mucositis or proctitis resulting from chemotherapy or radiation therapy of cancer in an animal |
| 05/20/2003 | US6566335 Administering a peptide derivative for mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood |
| 05/20/2003 | US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone |
| 05/20/2003 | US6566324 Preventing airway mucus production by administration of EGF-R antagonists |
| 05/20/2003 | US6566140 Inhibition of coagulation in blood and blood products |
| 05/20/2003 | US6566087 Detection of preferential enzymatic polypeptide; obtain sample containing enzymatic polypeptide, expose to modulator, monitor binding, detect adjustment in enzyme activity |
| 05/20/2003 | US6565869 Administering genetic engineered polypeptide |
| 05/20/2003 | US6565851 Relieving symptoms of erectile dysfunction with proanthocyanidins |
| 05/20/2003 | US6565829 Psychological disorders; central nervous system disorders |
| 05/20/2003 | CA2322944C Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 05/20/2003 | CA2289219C 1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines |
| 05/20/2003 | CA2234239C Indole carbamates as leukotriene antagonists |
| 05/20/2003 | CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties |
| 05/20/2003 | CA2117059C Pyrido-pyridazinone and pyridazinthione compounds |
| 05/20/2003 | CA2070524C Retinoids substituted by a dithiane cyclic and their use, process for the preparation of these compounds, cosmetic and pharmaceutical compositions containing them and therapeutical use of said compositions |
| 05/15/2003 | WO2003041128A2 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 05/15/2003 | WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS |
| 05/15/2003 | WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/15/2003 | WO2003040346A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 05/15/2003 | WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 05/15/2003 | WO2003040337A2 Polyamide modulators of cox2 transcription |
| 05/15/2003 | WO2003040333A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 05/15/2003 | WO2003040310A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 05/15/2003 | WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 05/15/2003 | WO2003040174A2 Substituted amino ketone compounds |
| 05/15/2003 | WO2003040170A2 Antibodies to cd40 |
| 05/15/2003 | WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 05/15/2003 | WO2003040140A1 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 05/15/2003 | WO2003040138A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003040135A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003040131A1 Aminopyrimidines and pyridines |
| 05/15/2003 | WO2003040127A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
| 05/15/2003 | WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity |
| 05/15/2003 | WO2003040119A1 Angiogenesis inhibitors |
| 05/15/2003 | WO2003040118A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 05/15/2003 | WO2003040117A1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/15/2003 | WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 05/15/2003 | WO2003040112A1 Substituted diphenyl heterocycles useful for treating hcv infection |
| 05/15/2003 | WO2003040109A2 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | WO2003040108A1 Quinazoline derivatives as antitumor agents |
| 05/15/2003 | WO2003040106A1 Preparation and use of substituted imidazoles |
| 05/15/2003 | WO2003040105A1 Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same |
| 05/15/2003 | WO2003040102A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 05/15/2003 | WO2003040099A1 Preparation of benzosuberonylpiperidine compounds |
| 05/15/2003 | WO2003040098A1 Novel metalloproteinase inhibitors |
| 05/15/2003 | WO2003040097A1 Nitrogenous compounds, production process, and method of use thereof |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | WO2003040084A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 05/15/2003 | WO2003039793A1 Preparation of metallic nanoparticle with shell-crosslinked micelle as mold |
| 05/15/2003 | WO2003039616A1 Percutaneous transluminal drug delivery device |
| 05/15/2003 | WO2003039611A1 Method of forming normal regenerated tissue, the normal regenerated tissue, and method of calibrating senstivity and so on |
| 05/15/2003 | WO2003039599A1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 05/15/2003 | WO2003039597A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment |
| 05/15/2003 | WO2003039596A1 Photodynamic therapy for the treatment of hair loss |
| 05/15/2003 | WO2003039590A1 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides |
| 05/15/2003 | WO2003039585A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 05/15/2003 | WO2003039580A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 05/15/2003 | WO2003039576A1 Psp-94: use for treatment of hypercalcemia and bone metastasis |
| 05/15/2003 | WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 05/15/2003 | WO2003039573A1 TARGETING THE REVERSE MODE OF THE Na+/Ca2+ EXCHANGER FOR THE TREATMENT OF OPTIC NEUROPATHY ASSOCIATED WITH GLAUCOMA AND ISCHEMIC OPTIC NEUROPATHY |
| 05/15/2003 | WO2003039571A1 Improved use of antitumoral compound in cancer therapy |
| 05/15/2003 | WO2003039568A1 Anticancer compositions |
| 05/15/2003 | WO2003039567A1 Anticancer compositions |